Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuomas Mirtti

Showing results (51-60 of 125) with videos related to

Pageof 13
Sort By:
Oncoimmunology|January 10, 2022
T and NK cell abundance defines two distinct subgroups of renal cell carcinomaMoon Hee Lee, Petrus Järvinen, Harry Nísen, et al.
Cancers|October 13, 2021
Morphological Features Extracted by AI Associated with Spatial Transcriptomics in Prostate CancerEduard Chelebian, Christophe Avenel, Kimmo Kartasalo, et al.
Scandinavian Journal of Urology|September 8, 2016
Outcome of surgery for patients with renal cell carcinoma and tumour thrombus in the era of modern targeted therapySara V Tornberg, Harry Nisen, Harri Visapää, et al.
Cancer Research Communications|March 6, 2023
Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate CancerTeijo Pellinen, Kevin Sandeman, Sami Blom, et al.
European Journal of Epidemiology|August 2, 2017
A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationaleAnssi Auvinen, Antti Rannikko, Kimmo Taari, et al.
Cancer Medicine|February 24, 2024
Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinomaLassi Luomala, Kalle Mattila, Paula Vainio, et al.
Human Pathology|February 16, 2018
New prostate cancer grade grouping system predicts survival after radical prostatectomyAndrew Erickson, Kevin Sandeman, Kanerva Lahdensuo, et al.
International Journal of Cancer|July 27, 2010
Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassayPekka Rappu, Camilla Nylund, Noora Ristiniemi, et al.
World Journal of Urology|July 20, 2012
Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocolsNathan Perlis, Polat Turker, Peter J Bostrom, et al.
Oncotarget|August 23, 2018
Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomyJohanna K Björk, Ilmari Ahonen, Tuomas Mirtti, et al.
Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Oncoimmunology|January 10, 2022
T and NK cell abundance defines two distinct subgroups of renal cell carcinomaMoon Hee Lee, Petrus Järvinen, Harry Nísen, et al.
Cancers|October 13, 2021
Morphological Features Extracted by AI Associated with Spatial Transcriptomics in Prostate CancerEduard Chelebian, Christophe Avenel, Kimmo Kartasalo, et al.
Scandinavian Journal of Urology|September 8, 2016
Outcome of surgery for patients with renal cell carcinoma and tumour thrombus in the era of modern targeted therapySara V Tornberg, Harry Nisen, Harri Visapää, et al.
Cancer Research Communications|March 6, 2023
Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate CancerTeijo Pellinen, Kevin Sandeman, Sami Blom, et al.
European Journal of Epidemiology|August 2, 2017
A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationaleAnssi Auvinen, Antti Rannikko, Kimmo Taari, et al.
Cancer Medicine|February 24, 2024
Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinomaLassi Luomala, Kalle Mattila, Paula Vainio, et al.
Human Pathology|February 16, 2018
New prostate cancer grade grouping system predicts survival after radical prostatectomyAndrew Erickson, Kevin Sandeman, Kanerva Lahdensuo, et al.
International Journal of Cancer|July 27, 2010
Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassayPekka Rappu, Camilla Nylund, Noora Ristiniemi, et al.
World Journal of Urology|July 20, 2012
Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocolsNathan Perlis, Polat Turker, Peter J Bostrom, et al.
Oncotarget|August 23, 2018
Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomyJohanna K Björk, Ilmari Ahonen, Tuomas Mirtti, et al.
Pageof 13